ASSOCIATION OF TNF AND LTA GENES WITH ATHEROSCLEROSIS COMPLICATIONSIN PATIENTS WITH HISTORY OF ACUTE CORONARY SYNDROME
- Authors: Zateyshchikov DA1, Pushkov AA1, Nikitin AG1, Brovkin AN1, Evdokimova MA1, Baklanova TN1, Tereschenko SN1, Dzhaiani NA1, Akatova EV1, Glezer MG1, Galyavich AS1, Koziolova NA1, Yagoda AV1, Boyeva OI1, Horolets EV1, Shlyk SV1, Volkova EG1, Konstantinov VO1, Nosikov VV1, Blagodatskih KA1
-
Affiliations:
- Issue: Vol 4, No 1 (2013)
- Pages: 4-11
- Section: Articles
- URL: https://journals.eco-vector.com/clinpractice/article/view/8243
- DOI: https://doi.org/10.17816/clinpract414-11
- ID: 8243
Cite item
Full Text
Abstract
Full Text
АССОЦИАЦИЯ ГЕНОВ TNF И LTA С ОСЛОЖНЕНИЯМИ АТЕРОСКЛЕРОЗА У БОЛЬНЫХ, ПЕРЕНЕСШИХ ОБОСТРЕНИЕИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦАAbout the authors
D A Zateyshchikov
Email: dz@bk.ru
A A Pushkov
A G Nikitin
A N Brovkin
M A Evdokimova
T N Baklanova
S N Tereschenko
N A Dzhaiani
E V Akatova
M G Glezer
A S Galyavich
N A Koziolova
A V Yagoda
O I Boyeva
E V Horolets
S V Shlyk
E G Volkova
V O Konstantinov
V V Nosikov
Email: nosikov@genetika.ru
K A Blagodatskih
References
- Оганов Р.Г., Масленникова Г.Я. Вклад сердечно-сосудистых и других неинфекционных заболеваний в здоровье населения России. Сердце. 2003; 2: 58-61.
- Шевченко О.П., Мишнев О.Д. Ишемическая болезнь сердца. М.: Реафарм. 2005. 416 с.
- Goyal A., Blazing M. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event? Am Heart J. 2005; 150: 650-651.
- Аронов Д.А. Первичная и вторичная профилактика сердечно-сосудистых заболеваний – интерполяция на Россию. Сердце. 2002; 3:109-112.
- Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: Basic Mechanisms: Oxidation, Inflammation, and Genetics. Circulation 1995;91 (9): 2488-96.
- de Craen A.J., Posthuma D., Remarque E.J., van den Biggelaar A.H., Westendorp R.G., Boomsma D.I. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 2005; 6: 167-170.
- Jermendy G., Horváth T., Littvay L., et al. Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study. Cardiovasc Diabetol 2011;10: 96.
- Raman K., Chong M., Akhtar-Danesh G.G., et al. Genetic markers of inflammation and their role in cardiovascular disease. Can J Cardiol. 2012; Sep 19 [Epub ahead of print].
- Благодатских К.А., Агапкина Ю.В., Никитин А.Г. и соавт. Полиморфные маркеры G(-174)C гена IL6 и G(-1082)A гена IL10 и генетическая предрасположенность к неблагоприятному течению ишемической болезни сердца у больных, перенесших острый коронарный синдром. Молекулярная биология. 2010;44(5): 839-846.
- Благодатских К.А., Никитин А.Г., Пушков А.А., и соавт. Полиморфные маркеры G2667C, G3014A, C3872T, A5237G гена CRP и генетическая предрасположенность к неблагоприятному течению ишемической болезни сердца у больных, перенесших обострение ишемической болезни сердца. Медицинская генетика. 2011;4: 3-9.
- Carroll M.C., Katzman P., Alicot E.M. et al. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci. 1987;84: 8535-9.
- Barath P., Fishbein M.C., Cao J., et al. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol. 1990;137(3): 503-9.
- Vaddi K., Nicolini F.A., Mehta P., Mehta J.L. Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation. Circulation. 1994; 90 (2): 694-9.
- Fernandez-Real J.M., Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev. 2003;24(3):278-301.
- Pai J.K., Pischon T., Ma J., Manson J.E., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004; 351(25): 2599-2610.
- Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 8: 2317-22.
- Wilson A.G., di Giovine F.S., Blakemore A.I., Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1(5): 353.
- Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci. 1997; 94(7): 3195-9.
- Laxton R., Pearce E., Kyriakou T., Ye S. Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary at herosclerosis. Genes Immun. 2005; 6(6): 539-41.
- Mathew C.G. The isolation of high molecular weight eukaryotic DNA. Methods Mol Biol. 1985; 2: 31-4.
- R Development Core Team. R: A language and environment for statistical computing. R foundation for Statistical Computing. Vienna, Austria, 2010. Available from www.r-project.org.
- Koch W., Tiroch K., von Beckerath N., Schomig A., Kastrati A. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine. 2003;24(4): 161-171.
- Yamada A., Ichihara S., Murase Y., Kato T., et al. Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese. J Mol Med. 2004;82(7): 477-83.
- Clarke R., Xu P, Bennett D., Lewington S., et al. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2006;2(7): e107.
- Zhang H.F., Xie S.L., Wang J.F., Chen Y.X., Wang Y., Huang T.C.Tumor necrosis factor-alpha G-308A gene polymorphism and coronary heart disease susceptibility: an updated meta-analysis. Thromb Res. 2011;127(5):400-5.
- Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol. 2001;88(8A):10K-15K.
- Allen RD. Polymorphism of the human TNF-alpha promoter – random variation or functional diversity? Mol Immunol. 1999; 36(15-16): 1017-27.